Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma

M. T. Tetzlaff, C. Adhikari, S. Lo, R. V. Rawson, R. N. Amaria, A. M. Menzies, J. S. Wilmott, P. M. Ferguson, M. I. Ross, A. J. Spillane, K. A. Vu, J. Ma, J. Ning, L. E. Haydu, R. P.M. Saw, J. A. Wargo, H. A. Tawbi, J. E. Gershenwald, G. V. Long, M. A. DaviesR. A. Scolyer

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences